A double-blind placebo-controlled randomized trial of oral saffron in the treatment of rheumatoid arthritis.

Abstract

In summary, patients who received pure saffron pills (100 mg/day) in addition to standard therapy did not have a significant difference in improvement of disease activity from the patients on standard therapy.